CareDx v. Natera — Federal Circuit Strikes Down Organ Transplant Rejection Diagnostic Patents Under § 101
The Federal Circuit held that Stanford University’s patents on detecting organ transplant rejection via donor cell-free DNA are ineligible under § 101, finding the claims directed to a natural phenomenon measured by conventional techniques.